NDC 67184-0535-01 - Decitabine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67184-0535
- Requested NDC
- 67184-0535-01
- Package NDCs from labels
- 67184-0535-1, 67184-0535-01
- Manufacturer
- Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd.
- Effective date
- 2021-10-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Decitabine | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. | 2021-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67184-0535-1 | Decitabine | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | 2 | |
| 67184-0535-1 | Decitabine | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67184-0535 | DECITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [QILU PHARMACEUTICAL CO., LTD.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20211020_5b2dce6f-c715-47dc-971e-06244ccd7548.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Helleborus comp. A | HELLEBORUS COMP. A | Uriel Pharmacy Inc. | 150e57ad-3ed7-5cc9-e063-6394a90a25fe | 2025-11-21 | Warnings | 4J9FJ0HL51 |
| Ionosol MB and Dextrose | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ICU Medical Inc. | 1b457b1d-0e80-4578-ba6f-dedf513fc962 | 2025-10-30 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Hospira, Inc. | 2fcbc814-c7a4-469a-8b1d-6819b961bfb9 | 2025-09-30 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | BluePoint Laboratories | de303068-589e-4e0a-90ed-e60b2c1a2b56 | 2025-09-29 | Warnings, Adverse reactions | 636631 776B62CQ27 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES IN SODIUM CHLORIDE | Amneal Pharmaceuticals LLC | dce22c93-aa48-48a9-ac8b-716400d33c9e | 2025-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | BluePoint Laboratories | 00caa305-fef4-471b-b9c3-4bcf5fe7b244 | 2025-08-05 | Warnings, Adverse reactions | ANDA212826 636631 776B62CQ27 |
| Decitabine | DECITABINE | Meitheal Pharmaceuticals Inc. | a3771445-1c68-4883-a014-74f8793f3136 | 2025-07-23 | Warnings, Adverse reactions | 636631 776B62CQ27 |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Fresenius Kabi USA, LLC | 357c3020-ea6f-4401-a2e7-cebb82b03144 | 2025-04-15 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Bestmade Natural Products BM182 Pellets | GRAPHITES, HEPAR SULF, MERC SOL, MURIATIC ACID | Bestmade Natural Products | 3242e013-2952-2b56-e063-6294a90a1693 | 2025-04-08 | Warnings | QTT17582CB |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Cipla USA Inc. | f1f26a17-d2e2-48f5-9054-8ee7e380556e | 2025-02-28 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | Fresenius Kabi USA, LLC | 475f5cd7-45bd-412a-b419-9962585d6cda | 2025-02-28 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Bestmade Natural Products BM62 | AMMONIUM BENZOICUM, AURUM MUR, CALC ARS, CARDUUS MAR, CROTALUS HORRIDUS, MURIATIC ACID, NUX VOM, PHOSPHORUS, VIPERA | Bestmade Natural Products | 2ce99cb7-fe9e-5da2-e063-6294a90afc4e | 2025-01-30 | Warnings | QTT17582CB |
| D-114 | ALUMINUM METALLICUM, AILANTHUS, BAPTISIA TINCTORIA, FRAGARIA VESCA, YOSCYAMUS NIGER, MURIATICUM ACID | DNA Labs | f6f7d369-64ef-0ed9-e053-6294a90a40fa | 2025-01-13 | Warnings | QTT17582CB |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS IUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOSPHORUS, STAPHYSAGRIA, STRAMONIUM | Silver Star Brands | 05e04129-e7c1-4e11-e063-6394a90a09ca | 2025-01-01 | Warnings | QTT17582CB |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 89136c51-a60b-4269-bd05-9489f060a734 | 2024-12-31 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| decitabine | DECITABINE | Hikma Pharmaceuticals USA Inc. | 8c5d6067-16a1-43ab-9e52-a33c600a5c44 | 2024-12-26 | Warnings, Adverse reactions | 636631 776B62CQ27 |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS LUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOS, STAPHYSAG, STRAMONIUM | Silver Star Brands | 9d75666e-3214-2bab-e053-2a95a90af719 | 2024-12-03 | Warnings | QTT17582CB |
| Potassium Phosphate | POTASSIUM PHOSPHATE | Somerset Therapeutics, LLC | 52f07402-1869-4a97-9c92-9729dc611f85 | 2024-07-11 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | Accord Healthcare Inc. | b46df7d7-d98e-4c7e-b1ee-e03e258781c4 | 2024-07-09 | Warnings, Adverse reactions | 636631 776B62CQ27 |
| Decitabine | DECITABINE | Camber Pharmaceuticals, Inc. | 5662c353-05d0-4bd8-87e4-c92ec9ca861e | 2024-06-26 | Warnings, Adverse reactions | 636631 776B62CQ27 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.